Cargando…
Suppression of CD300A inhibits the growth of diffuse large B-cell lymphoma
CD300A is a type I transmembrane receptor protein which has shown inhibitory effects on B-cell receptor-mediated signals. In an analysis of public dataset, we found that CD300A mRNA levels were inversely correlated with the overall survival time of patients with diffuse large B-cell lymphoma (DLBCL)...
Autores principales: | Jiang, Lei, Xu, Yulian, Zeng, Xinli, Fang, Jianchen, Morse, Herbert C., Zhou, Jeff X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741597/ https://www.ncbi.nlm.nih.gov/pubmed/26435477 |
Ejemplares similares
-
Correction: Suppression of CD300A inhibits the growth of diffuse large B-cell lymphoma
por: Jiang, Lei, et al.
Publicado: (2017) -
Loss of IRF8 Inhibits the Growth of Diffuse Large B-cell Lymphoma
por: Xu, Yulian, et al.
Publicado: (2015) -
Diffuse Large B-Cell Lymphoma Promotes Endothelial-to-Mesenchymal Transition via WNT10A/Beta-Catenin/Snail Signaling
por: Sun, Xianting, et al.
Publicado: (2022) -
Plasma Factors for the Differentiation of Hodgkin’s Lymphoma and Diffused Large B Cell Lymphoma and for Monitoring Remission
por: Zeng, Qun, et al.
Publicado: (2019) -
Leukemic Phase of CD5+ Diffuse Large B-Cell Lymphoma
por: Hsiao, Hui-Hua, et al.
Publicado: (2018)